Article Results (Showing 1 - 10 of 188) RSS Alert
-
Genentech seeks early approval for oncology drug.(Life Sciences)

GENENTECH INC. is seeking early approval for its newest oncology product Avastin (bevacizumab) with its filing of a completed biologics license...
Chemical Market Reporter, 10/06/03 by Mirasol, Feliza · More from publication -
New antibiotics launch is first in its class.(Life Sciences)

ANSWERING THE call for new antibiotics to treat serious infections, Cubist Pharmaceuticals Inc. will soon launch its lead product, Cubicin...
Chemical Market Reporter, 09/29/03 by Mirasol, Feliza · More from publication -
Launch of Genentech's Raptiva moves toward final FDA approval.(Life Sciences)

AFTER A DELAY that halted the launch of Genentech Inc.'s psoriasis drug Raptiva (efalizumab) earlier this year, a Food and Drug Administration...
Chemical Market Reporter, 09/15/03 by Mirasol, Feliza · More from publication -
Amgen settles dispute with Genentech.(Life Sciences)(out of court settlement)

AFTER ALMOST a decade of patent litigation, biotech majors Amgen Inc. and Genentech Inc. resolved their dispute over Amgen's anti-infection drugs...
Chemical Market Reporter, 09/08/03 by Mirasol, Feliza · More from publication -
Guar Gum Market Softens After Three Strong Years.(Brief Article)

Prices are falling in response to recovering supplies. AFTER THREE consecutive years of radically high prices because of tight supplies, the...
Chemical Market Reporter, 08/28/00 by MIRASOL, FELIZA · More from publication -
New Pharma Landscape May Lead to Further M&As.(Brief Article)

BMS, Merck and SP have reason to look, say analysts. AMIDST A SEA of familiar yet new faces emerging in the pharmaceutical industry,...
Chemical Market Reporter, 08/21/00 by MIRASOL, FELIZA · More from publication -
Mapping the Human Genome Is Only the Beginning.(biotechnology industry)(Statistical Data Included)

Functional genomics and enabling technologies stand to benefit from the progress made in sequencing of the full human genome. The creation...
Chemical Market Reporter, 08/21/00 by Mirasol, Feliza · More from publication -
Amino Acids Promise Growth in Steady Markets.(Brief Article)(Statistical Data Included)

Their use as flavoring agents is briskly on the rise. THE MARKET outlook for amino acids is generally positive. New commercial applications...
Chemical Market Reporter, 08/14/00 by MIRASOL, FELIZA · More from publication -
Genomics Firms Rebound In Recent Sector Upswing.(Brief Article)(Statistical Data Included)

PE Biosystems celebrates its role in decoding the genome. FOLLOWING A positive upswing since the end of this year's first quarter, the...
Chemical Market Reporter, 08/07/00 by MIRASOL, FELIZA · More from publication -
Drug Majors Post Strong Second Quarter Earnings.(Statistical Data Included)

Growth attributed to strong top-line performance. DRUG GIANTS American Home Products Corporation, Bristol-Myers Squibb Company, Eli Lilly...
Chemical Market Reporter, 07/31/00 by MIRASOL, FELIZA · More from publication
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn’t Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid


